Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 412.00
-38.00 (-8.44%)
Jul 27, 2026, 4:35 PM GMT
Tristel Market Cap
Tristel has a market cap or net worth of 197.7 million as of July 27, 2026. Its market cap has increased by 11.99% in one year.
Market Cap
197.70M
Enterprise Value
190.24M
Revenue
49.54M
Ranking
n/a
PE Ratio
25.37
Stock Price
412.00
ChartMarket Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 197.70M, an increase of 2,762.36%. That is a compound annual growth rate of 17.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 197.70M | -0.86% |
| Dec 31, 2025 | 199.42M | -1.61% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.51B |
| GSK plc | 76.44B |
| Haleon | 32.02B |
| Smith & Nephew | 9.59B |
| Allergy Therapeutics | 378.69M |
| Avacta Group | 327.88M |
| PureTech Health | 299.40M |
| NIOX Group | 267.56M |